National Health Investors, Inc. (NHI)
USD 68.9
(-4.0%)
USD 68.9
(-4.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 184.45 Million | 185.34 Million | 210.85 Million | 232.14 Million | 240.95 Million | 207.86 Million |
| Net Income | 134.38 Million | 65.5 Million | 111.96 Million | 185.31 Million | 160.44 Million | 154.33 Million |
| Depreciation & Amortization | 69.97 Million | 70.88 Million | 80.79 Million | 83.15 Million | 76.81 Million | 75.78 Million |
| Deferred income taxes | -15.2 Million | - | -29.04 Million | -14.26 Million | 823 Thousand | 5.85 Million |
| Stock-based compensation | 4.6 Million | 8.61 Million | 8.41 Million | 3.06 Million | 3.64 Million | 2.49 Million |
| Change in working capital | 3.28 Million | -2.69 Million | -438 Thousand | -6.73 Million | 18.7 Million | -571 Thousand |
| Other non-cash items | -12.59 Million | 43.04 Million | 39.15 Million | -18.37 Million | -19.47 Million | -30.02 Million |
| Investing Cash Flow | -11.63 Million | 197.94 Million | 185.27 Million | -89.71 Million | -342.52 Million | -250.29 Million |
| Investments in PPE | -3.74 Million | -4.62 Million | -64 Thousand | -13.85 Million | -17.99 Million | -147.64 Million |
| Acquisitions | 2.97 Million | 11.73 Million | -187.53 Million | -875 Thousand | 643 Thousand | - |
| Investment purchases | -77.44 Million | -86.16 Million | -119.11 Million | -162.1 Million | -327.41 Million | -238.74 Million |
| Sales/Maturities of investments | 70.49 Million | 288.17 Million | 306.65 Million | 86.24 Million | 2.89 Million | 4.34 Million |
| Other Investing Activities | -3.9 Million | -11.16 Million | 185.34 Million | 875 Thousand | -643 Thousand | -102.64 Million |
| Financing Cash Flow | -169.71 Million | -401.25 Million | -402.99 Million | -111.76 Million | 107.32 Million | 44.25 Million |
| Debt repayment | -576.42 Million | -318.38 Million | -752.39 Million | -54.27 Million | -23.65 Million | -131.87 Million |
| Dividends payments | -156.23 Million | -161.77 Million | -182.9 Million | -194.58 Million | -179.73 Million | -165.39 Million |
| Common Stock Repurchased | - | -151.95 Million | 491.78 Million | -2.7 Million | -1.55 Million | -1.83 Million |
| Common Stock Issuance | - | - | 47.9 Million | 34.64 Million | 95.77 Million | 81.78 Million |
| Other Financing Activities | 562.94 Million | 230.85 Million | -7.39 Million | 31.25 Million | 216.5 Million | 79.61 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 5.92 Million | 425 Thousand | 3.35 Million | -6.68 Million | 300 Thousand | 4.58 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.64 Million | -3.12 Million | -3.79 Million | -57 Thousand | 18.4 Million | -5.15 Million |
| Cash at beginning of period | 21.51 Million | 39.48 Million | 46.34 Million | 15.66 Million | 9.91 Million | 8.07 Million |
| Cash at end of period | 24.61 Million | 21.51 Million | 39.48 Million | 46.34 Million | 15.66 Million | 9.91 Million |
| Capital Expenditure | -3.74 Million | -4.62 Million | -64 Thousand | -13.85 Million | -17.99 Million | -147.64 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3.1 Million | -17.96 Million | -6.85 Million | 30.67 Million | 5.75 Million | 1.83 Million |
| Free Cash Flow | 180.7 Million | 180.71 Million | 210.79 Million | 218.29 Million | 222.95 Million | 60.22 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 27.64 Million | 35.25 Million | 30.94 Million | 134.38 Million | 31.71 Million | 29.03 Million |
| Depreciation & Amortization | 16.32 Million | 18.21 Million | 18.22 Million | 69.97 Million | 17.11 Million | 17.51 Million |
| Deferred income taxes | - | - | - | -15.2 Million | -1.77 Million | -737 Thousand |
| Stock-based compensation | 670 Thousand | 687 Thousand | 2.15 Million | 4.6 Million | 865 Thousand | 866 Thousand |
| Change in working capital | 4.7 Million | 6.88 Million | -11.58 Million | 3.28 Million | 4.65 Million | 681 Thousand |
| Other non-cash items | -1.11 Million | 30.8 Million | 47.38 Million | -12.59 Million | 626 Thousand | 2.34 Million |
| Investing Cash Flow | -1.24 Million | -13.51 Million | -16.35 Million | -11.63 Million | 2.33 Million | -19.94 Million |
| Investments in PPE | 5.03 Million | -2.74 Million | -2.29 Million | -3.74 Million | -1.16 Million | -1.09 Million |
| Acquisitions | -70 Thousand | 70 Thousand | - | 2.97 Million | -22.86 Million | 19.94 Million |
| Investment purchases | 37.99 Million | -21.3 Million | -16.68 Million | -77.44 Million | 73.76 Million | -23.5 Million |
| Sales/Maturities of investments | -13 Million | 10.38 Million | 2.62 Million | 70.49 Million | -62.77 Million | 4.66 Million |
| Other Investing Activities | -31.19 Million | 82 Thousand | -13.38 Million | -3.9 Million | 15.37 Million | -19.94 Million |
| Financing Cash Flow | 79.8 Million | -43.88 Million | -35.92 Million | -169.71 Million | -49.41 Million | -30.53 Million |
| Debt repayment | -7.51 Million | -4.11 Million | -3.39 Million | -576.42 Million | -91.12 Million | -43.1 Million |
| Dividends payments | -39.09 Million | -39.08 Million | -39.06 Million | -156.23 Million | -39.06 Million | -39.06 Million |
| Common Stock Repurchased | 400 Thousand | -400 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 126.01 Million | -685 Thousand | -248 Thousand | 562.94 Million | 80.77 Million | 51.63 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -2.2 Million | 6.24 Million | -7.52 Million | 5.92 Million | 4.61 Million | 541 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.42 Million | 635 Thousand | -4.06 Million | -2.64 Million | 46 Thousand | 140 Thousand |
| Cash at beginning of period | 14.76 Million | 11.35 Million | 22.34 Million | 21.51 Million | 18.49 Million | 19.27 Million |
| Cash at end of period | 141.55 Million | 14.76 Million | 11.35 Million | 24.61 Million | 24.61 Million | 18.49 Million |
| Capital Expenditure | 5.03 Million | -2.74 Million | -2.29 Million | -3.74 Million | -1.16 Million | -1.09 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 126.79 Million | 3.4 Million | -10.99 Million | 3.1 Million | 6.12 Million | -779 Thousand |
| Free Cash Flow | 53.26 Million | 58.22 Million | 38.7 Million | 180.7 Million | 52.03 Million | 48.6 Million |
RAILTEL
POLYMED
WYNMF
002962
ORRYY
CHI